Suya Du

733 total citations
15 papers, 551 citations indexed

About

Suya Du is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Suya Du has authored 15 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Suya Du's work include Mangiferin and Mango Extracts (3 papers), DNA Repair Mechanisms (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Suya Du is often cited by papers focused on Mangiferin and Mango Extracts (3 papers), DNA Repair Mechanisms (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Suya Du collaborates with scholars based in China and Switzerland. Suya Du's co-authors include Yi Wang, Rongsheng Tong, Tiantian Lei, Tiantian Lei, Hailian Wang, Xia He, Xiaofang Xie, Huirong Liu, Lin Chen and Dandan Qi and has published in prestigious journals such as Frontiers in Immunology, Oncotarget and Frontiers in Pharmacology.

In The Last Decade

Suya Du

15 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suya Du China	12	278	100	79	73	69	15	551
Zhao Wu China	13	350 1.3×	49 0.5×	96 1.2×	32 0.4×	80 1.2×	38	638
Hongjiao Xiang China	13	285 1.0×	46 0.5×	97 1.2×	37 0.5×	38 0.6×	21	537
Yuqin Wang China	16	385 1.4×	56 0.6×	108 1.4×	60 0.8×	126 1.8×	26	663
Enhong Xing China	15	182 0.7×	66 0.7×	74 0.9×	26 0.4×	71 1.0×	30	470
Yuming Huang China	13	228 0.8×	69 0.7×	98 1.2×	31 0.4×	58 0.8×	25	580
Yitao Ou China	13	300 1.1×	52 0.5×	70 0.9×	29 0.4×	121 1.8×	19	603
Shuya Zhang China	12	304 1.1×	24 0.2×	62 0.8×	80 1.1×	84 1.2×	21	594
Xianghui Ma China	12	219 0.8×	46 0.5×	98 1.2×	36 0.5×	55 0.8×	21	443
Heran Wang China	11	388 1.4×	84 0.8×	179 2.3×	35 0.5×	48 0.7×	24	686
Yunpeng Xie China	15	347 1.2×	29 0.3×	99 1.3×	35 0.5×	100 1.4×	43	574

Countries citing papers authored by Suya Du

Since Specialization

Citations

This map shows the geographic impact of Suya Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suya Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suya Du more than expected).

Fields of papers citing papers by Suya Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suya Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suya Du. The network helps show where Suya Du may publish in the future.

Co-authorship network of co-authors of Suya Du

This figure shows the co-authorship network connecting the top 25 collaborators of Suya Du. A scholar is included among the top collaborators of Suya Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suya Du. Suya Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Luo, Jing, et al.. (2023). The sound and surprise: overlapping meta-analyses on the topic of safety and efficacy of PD-1 and PD-L1 inhibitors in the treatment of non-small cell lung cancer. European Journal of Clinical Pharmacology. 79(12). 1665–1673. 1 indexed citations

Liu, Yilong, Suya Du, Xia He, et al.. (2022). Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer. Frontiers in Pharmacology. 13. 949126–949126. 2 indexed citations

Lei, Tiantian, Lin Chen, Kejing Wang, et al.. (2022). Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps. Frontiers in Immunology. 13. 1031185–1031185. 23 indexed citations

Du, Suya, Yanjiao Li, Zhen Geng, et al.. (2022). Engineering Islets From Stem Cells: The Optimal Solution for the Treatment of Diabetes?. Frontiers in Immunology. 13. 869514–869514. 4 indexed citations

Luo, Jing, et al.. (2022). Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic Reviews. Frontiers in Immunology. 13. 953761–953761. 14 indexed citations

Lei, Tiantian, Suya Du, Zhe Peng, & Lin Chen. (2022). Multifaceted regulation and functions of 53BP1 in NHEJ‑mediated DSB repair (Review). International Journal of Molecular Medicine. 50(1). 37 indexed citations

He, Rui, Suya Du, Tiantian Lei, Xiaofang Xie, & Yi Wang. (2020). Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review). Oncology Reports. 44(6). 2373–2385. 44 indexed citations

Wang, Yi, et al.. (2019). Xenotransplantation in China: Present status. Xenotransplantation. 26(1). e12490–e12490. 32 indexed citations

Liu, Yuping, Ting Liu, Tiantian Lei, et al.. (2019). RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review). International Journal of Molecular Medicine. 44(3). 771–786. 117 indexed citations

10.

Liu, Ting, Hanrui Zheng, Xiaofang Xie, et al.. (2018). Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining. Oncology Reports. 40(6). 3663–3673. 15 indexed citations

11.

Lei, Tiantian, Suya Du, Rongsheng Tong, et al.. (2018). Nuclear GSK3β induces DNA double-strand break repair by phosphorylating 53BP1 in glioblastoma. International Journal of Oncology. 52(3). 709–720. 24 indexed citations

12.

Du, Suya, Huirong Liu, Tiantian Lei, et al.. (2018). Mangiferin: An effective therapeutic agent against several disorders (Review). Molecular Medicine Reports. 18(6). 4775–4786. 108 indexed citations

13.

You, Yaodong, Suya Du, Tiantian Lei, et al.. (2018). Anti‑neoplastic effect of mangiferin on human ovarian adenocarcinoma OVCAR8 cells via the regulation of YAP. Oncology Letters. 17(1). 1008–1018. 12 indexed citations

14.

Liu, Huirong, Suya Du, Tiantian Lei, et al.. (2018). Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Oncology Reports. 40(1). 16–28. 76 indexed citations

15.

He, Xia, Suya Du, Tiantian Lei, et al.. (2017). PKM2 in carcinogenesis and oncotherapy. Oncotarget. 8(66). 110656–110670. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact